Cargando…

A peripheral blood transcriptome biomarker test to diagnose functional recovery potential in advanced heart failure

Heart failure (HF) is a complex clinical syndrome that causes systemic hypoperfusion and failure to meet the body’s metabolic demands. In an attempt to compensate, chronic upregulation of the sympathetic nervous system and renin-angiotensin-aldosterone leads to further myocardial injury, HF progress...

Descripción completa

Detalles Bibliográficos
Autor principal:	Deng, Mario C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2018
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479277/ https://www.ncbi.nlm.nih.gov/pubmed/29737882 http://dx.doi.org/10.2217/bmm-2018-0097

Ejemplares similares

Comparing NGS and NanoString platforms in peripheral blood mononuclear cell transcriptome profiling for advanced heart failure biomarker development
por: Bondar, Galyna, et al.
Publicado: (2020)

Peripheral Blood NRF2 Expression as a Biomarker in Human Health and Disease
por: Neilson, Lee E., et al.
Publicado: (2020)

Using left ventricular assist devices in advanced heart failure patients
por: Shah, Syed Raza, et al.
Publicado: (2018)

Erythropoietin enhanced recovery after peripheral nerve injury
por: Modrak, Max, et al.
Publicado: (2017)

The transcriptomic profile of peripheral blood nuclear cells in dogs with heart failure
por: Hulanicka, Magdalena, et al.
Publicado: (2014)

Advancing the Science of Myocardial Recovery With Mechanical Circulatory Support: A Working Group of the National, Heart, Lung, and Blood Institute
por: Drakos, Stavros G., et al.
Publicado: (2017)

Heart Failure: Gaps in Knowledge and Failures in Treatment
por: Burch, Druin
Publicado: (2014)

Blood eosinophils in chronic obstructive pulmonary disease: A potential biomarker
por: Cui, Yanan, et al.
Publicado: (2023)

PDE5 inhibitors promote recovery of peripheral neuropathy in diabetic mice
por: Wang, Lei, et al.
Publicado: (2017)

Heart failure and healthcare informatics
por: Anwar, Mohamed S., et al.
Publicado: (2019)

Medical Therapies for Heart Failure in Hypoplastic Left Heart Syndrome
por: Baybayon-Grandgeorge, Angela N., et al.
Publicado: (2022)

Advance of Peripheral Nerve Injury Repair and Reconstruction
por: Jiang, Bao-Guo, et al.
Publicado: (2017)

Peripheral Arterial Disease and Metals in Urine and Blood
por: Plusquin, Michelle, et al.
Publicado: (2005)

Advances in spatial transcriptomic data analysis
por: Dries, Ruben, et al.
Publicado: (2021)

Transcriptomal Insights of Heart Failure from Normality to Recovery
por: Quttainah, Mohammed, et al.
Publicado: (2022)

Comparison of Whole Blood and Peripheral Blood Mononuclear Cell Gene Expression for Evaluation of the Perioperative Inflammatory Response in Patients with Advanced Heart Failure
por: Bondar, Galyna, et al.
Publicado: (2014)

To Test, Perchance to Diagnose: Practical Strategies for Severe Acute Respiratory Syndrome Coronavirus 2 Testing
por: Humphries, Romney M, et al.
Publicado: (2021)

Plerixafor use for peripheral blood stem cell mobilization in Korea
por: Kim, Seok Jin, et al.
Publicado: (2013)

Heart Failure Pharmacological Management: Gaps and Current Perspectives
por: Severino, Paolo, et al.
Publicado: (2023)

Delayed peripheral treatment with neurotrophin-3 improves sensorimotor recovery after central nervous system injury
por: Kakanos, Sotiris G., et al.
Publicado: (2019)

Advances in diet-induced rodent models of metabolically acquired peripheral neuropathy
por: Eid, Stéphanie A., et al.
Publicado: (2021)

Atrial fibrillation and heart failure- results of the CASTLE-AF trial
por: Shah, Syed Raza, et al.
Publicado: (2018)

Hydralazine and nitrates in the treatment of heart failure with reduced ejection fraction
por: Al‐Mohammad, Abdallah
Publicado: (2019)

The influence of arterial stiffness in heart failure: a clinical review
por: Feola, Mauro
Publicado: (2021)

Effect of atrial fibrillation on cognitive function in heart failure patients
por: Ktenopoulos, Nikolaos, et al.
Publicado: (2021)

Acetazolamide for patients with acute decompensated heart failure with volume overload( )
por: Rossello, Xavier, et al.
Publicado: (2022)

Association between preoperative peripheral blood mononuclear cell gene expression profiles, early postoperative organ function recovery potential and long-term survival in advanced heart failure patients undergoing mechanical circulatory support
por: Bondar, Galyna, et al.
Publicado: (2017)

A Blood Test for Lung Fibrosis
por: Barnes, Peter J
Publicado: (2008)

Microparticles as Novel Biomarkers and Therapeutic Targets in Coronary Heart Disease
por: Zhou, Bo-Da, et al.
Publicado: (2015)

Cellular reprogramming and inherited peripheral neuropathies: perspectives and challenges
por: Saporta, Mario A.
Publicado: (2015)

Immunometabolism and potential targets in severe COVID-19 peripheral immune responses
por: Wang, Shanshan, et al.
Publicado: (2021)

Exploring Guidelines for Classification of Major Heart Failure Subtypes by Using Machine Learning
por: Alonso-Betanzos, Amparo, et al.
Publicado: (2015)

Nursing care in old patients with heart failure: current status and future perspectives
por: PI, Hong-Ying, et al.
Publicado: (2016)

Left ventricular assist devices as destination therapy in stage D heart failure
por: Asleh, Rabea, et al.
Publicado: (2019)

Evidence Based Management of Acute Heart Failure in the Era of COVID-19 Pandemic
por: Wang, Lexin
Publicado: (2022)

The presence of functional blood vessels in the ischemic core provides a therapeutic target for stroke recovery
por: Morris, Gary P., et al.
Publicado: (2023)

Potential of the use of an antioxidant compound to promote peripheral nerve regeneration after injury
por: Gerhke, Sergio A., et al.
Publicado: (2015)

Vascular phenotypes of acute decompensated vs. new‐onset heart failure: treatment implications
por: Ferreira, Jorge
Publicado: (2017)

Targeting therapy for homocysteic acid in the blood represents a potential recovery treatment for cognition in Alzheimer's disease patients
por: Hasegawa, Tohru, et al.
Publicado: (2016)

Advancing Biosimilar Development Using Pharmacodynamic Biomarkers in Clinical Pharmacology Studies
por: Li, Junyi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_caabl198vopn2488h3fi9vt11g